Wockhardt Reports Q2 FY27 PAT of ₹73 Cr, Revenue Up 24%
Wockhardt Limited announced its un-audited financial results for the quarter and half-year ended September 30, 2026. The company reported a Profit After Tax (PAT) of ₹73 crore for Q2 FY27. Total revenue for Q2 FY27 grew by 24% year-on-year to ₹969 crore, compared to ₹782 crore in the previous year. EBITDA for the quarter stood at ₹165 crore. For the half-year ended H1 FY27, revenue increased by 25% to ₹1898 crore from ₹1520 crore in H1 FY26, with EBITDA growing by 35% to ₹353 crore. Biotech operations showed significant growth, with overall biotech revenue at ₹252 crore for Q2 FY27 (up 68% YoY) and ₹487 crore for H1 FY27 (up 87% YoY), driven by emerging markets. The India Branded Business grew 8% in Q2 FY27, and Emerging Markets saw a 52% revenue increase.
Key Highlights
- Q2 FY27 PAT reported at ₹73 Cr.
- Revenue surged 24% YoY to ₹969 Cr in Q2 FY27.
- H1 FY27 revenue up 25% YoY to ₹1898 Cr.
- Biotech operations grew 68% YoY in Q2 FY27.
- Emerging Markets revenue increased 52% YoY in Q2 FY27.
Price Impact
More from WOCKPHARMA